All Anna Wec articles
-
NewsA new generation of mRNA antibody therapies may tackle ever-evolving SARS-CoV-2 variants
Researchers have fashioned an advanced antibody therapy that can neutralize SARS-CoV-2 while constraining the virus’ ability to escape recognition. The therapy protected mice against infections with an immune-evasive Omicron variant, and provides a structural template for antiviral antibodies that can keep up with their constantly evolving viral targets.